Press Release

Institut Pasteur Korea announces enrollment period for 2017 autumn semester UST-IPK Master’s & Doctoral Programs

Pangyo, Gyeonggi, 2 Mar, 2017 | Institut Pasteur Korea announces March 2 ~ March 15, 2017 is the enrollment period for the University of Science and Technology (UST) - IPK 2017 autumn semester master’s & doctoral programs. The UST-IPK program (Major: Biological Chemistry) is a hands-on, on-site Research & Discovery education program designed for graduate students interested in infectious disease research and drug discovery.

Founded in 2004, UST aims to foster highly qualified R&D professionals in the field of new convergence technology through on-site R&D education. IPK became a member campus in 2014 and is the only non-profit research organization on the 33 member campus roster.

Space is limited as only 4 students will be allowed to participate. General admission for Koreans is March 9 ~ March 15, 2017 and special admission for foreigners and Koreans living overseas is March 2 ~ March 15, 2017. For more detailed information on the UST program, please visit To learn more about IPK, please go to or contact us at t: 031-8018-8041, e:

# # # # # #

About Institut Pasteur Korea
Institut Pasteur Korea (IPK) is an international research institute focused on addressing global health issues with a combination of cutting edge approaches in order to understand disease mechanisms and develop new treatments. By promoting multi-disciplinary projects, IPK is at the forefront of drug discovery and an economic growth engine that contributes to Korea's scientific intellectual and technical resources. IPK has four core missions of public interest; 1) Research, combining front line biology, IT, and chemistry, with innovative cell-based drug discovery platforms that identify novel molecular targets for potential new therapies to treat diseases, 2) Education, offering a wide range of programming to nurture the development of the next generation of scientists and health professionals, 3) Public Health, working in collaboration with national and international health authorities, and 4) Translation of biomedical discoveries to improve health via technology transfer and industrial partnerships.
IPK is a member of the Institut Pasteur International Network (Network). As a hub institution, IPK plays a key role in the Network, serving as a bridge between Korea and global bio-pharma science, expanding Korea's R&D base collaborative research projects with global alliances
The institute was established in April 2004 in collaboration with Institut Pasteur Paris and the Korea Institute of Science and Technology (KIST), with support from the Ministry of Science, ICT and Future Planning (MSIP). IPK also has a great supporter in the Gyeonggi Provincial government (2005 – 2015 : Block funding | 2016 – Present : drug discovery co-resarch fund for pharm industries).